Ask AI

Downloadable Slides

Share

Program Content

Activities

  • AntiCD38 for Smoldering and NDMM
    Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 13, 2026

  • AntiCD38 Tx for Smoldering and NDMM
    Optimizing Outcomes With Anti-CD38–Based Treatment for Smoldering and Newly Diagnosed Multiple Myeloma: Best Practices for Oncology Pharmacists #2 
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 19, 2026

  • Advances in SMM and NDMM
    Advances in Smoldering and Transplant-Eligible Newly Diagnosed Multiple Myeloma: Risk Stratification, MRD-Guided Therapy, and Emerging Treatment Strategies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 31, 2026

  • Transplant Ineligible NDMM
    Frontline Management of Transplant-Ineligible Multiple Myeloma: Optimizing Therapy, Supportive Care, and Patient Outcomes
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 31, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC.

Supporters

Supported by educational grants from Johnson & Johnson and Sanofi Genzyme.

Johnson & Johnson

Sanofi Genzyme